Product Information:

BEKSON FORTE HFA 250mcg MDI is a pressurized metered-dose inhaler containing Beclomethasone Dipropionate, a potent corticosteroid delivered via hydrofluoroalkane (HFA) propellant. It works by reducing inflammation, swelling, and mucus production in the airways, helping to prevent asthma attacks and manage chronic obstructive pulmonary disease (COPD). This formulation is non-CFC, environmentally friendly, and designed for consistent lung deposition with minimal oropharyngeal side effects.

Uses of (BEKSON FORTE HFA 250MCG MDI):

BEKSON FORTE is indicated for:

1. Prophylactic maintenance treatment of persistent asthma in adults and children (≥5 years).
2. Management of COPD in patients requiring regular inhaled corticosteroid therapy.
3. Reduction of exacerbation frequency and improvement of lung function when used regularly.

Key Benefits of (BEKSON FORTE HFA 250MCG MDI):

1. High-potency anti-inflammatory action at low systemic absorption
2. HFA propellant ensures fine particle delivery deep into the lungs
3. Reduces reliance on rescue bronchodilators over time
4. Non-CFC and ozone-friendly formulation
5. Once- or twice-daily dosing improves adherence

How To Use (BEKSON FORTE HFA 250MCG MDI):

Shake the inhaler well before each puff. Exhale fully, place mouthpiece in mouth, and inhale slowly while pressing down on the canister. Hold breath for 10 seconds, then exhale gently. Rinse mouth with water after use to prevent oral thrush. Do not exceed prescribed dose. Regular daily use is essential—even when asymptomatic.

When Not to Use (BEKSON FORTE HFA 250MCG MDI):

Do not use for acute asthma attacks or status asthmaticus—this is a controller, not a reliever. Avoid if hypersensitive to beclomethasone or HFA propellants. Not recommended as first-line monotherapy in mild intermittent asthma. Use in children <5 years only under specialist guidance.

Side Effects of (BEKSON FORTE HFA 250MCG MDI):

Common: Oral candidiasis (thrush), hoarseness, throat irritation, cough.

Rare but serious: Adrenal suppression (with long-term high doses), reduced bone mineral density, glaucoma, cataracts, or growth retardation in children. Systemic effects are uncommon at recommended doses.

Dosage: (BEKSON FORTE HFA 250MCG MDI):

Adults & adolescents (≥12 years): 1–2 puffs twice daily (250–500 mcg/day).

Maximum: 1000 mcg/day in divided doses under supervision.

Children (5–11 years): Lower-strength formulations preferred; use only if clearly needed. Always titrate to lowest effective dose.

Who It’s For (BEKSON FORTE HFA 250MCG MDI):

Patients with moderate to severe persistent asthma or COPD requiring inhaled corticosteroid therapy. Ideal for those needing higher steroid potency than standard beclomethasone doses. Not for acute symptom relief.

Warnings & Precautions:

Monitor growth in pediatric patients. Assess bone health in long-term users (>3 months). Avoid abrupt discontinuation—taper under supervision. Inform your doctor if you develop vision changes, persistent sore throat, or signs of infection. Carry a fast-acting bronchodilator (e.g., salbutamol) for emergencies.

Drug Interactions:

Ketoconazole and other strong CYP3A4 inhibitors may increase systemic corticosteroid exposure. No significant interactions with most common respiratory medications, but always disclose all inhalers or systemic drugs to your physician.

Additional Information:

Store below 30°C. Do not puncture, freeze, or expose to heat >50°C. Clean mouthpiece weekly with dry cloth—do not wash. Discard after labeled number of actuations (usually 200). Available by prescription only in Pakistan.